The original letter from Radaelli and Riva was edited for brevity and clarity. It is the policy of the Journal of Histochemistry & Cytochemistry, based on the recommendations of the Histochemical Society’s Standards of Practice Committee, to include the species, clonality, source, and clone name/catalog number of all antibodies that appear in articles.1 As the Histochemical Society’s leadership noted previously,2 this remains a chronic challenge in the biomedical literature. Having assumed the editorship in January 2016, I can attest to the challenge of reaching this goal and published this letter in an effort to maintain the highest standards in publication and reproducibility.
Stephen M. Hewitt,
Editor-in-Chief
Journal of Histochemistry & Cytochemistry
Truchas, New Mexico, USA.
E-mail: smhewitt@histochemicalsociety.org
Literature Cited
- 1. Hewitt SM, Baskin DG, Frevert CW, Stahl WL, Rosa-Molinar E. Controls for immunohistochemistry: the Histochemical Society’s standards of practice for validation of immunohistochemical assays. J Histochem Cytochem. 2014;62(10):693–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Baskin DG, Hewitt SM. Improving the state of the science of immunohistochemistry: the Histochemical Society’s standards of practice. J Histochem Cytochem. 2014; 62(10):691–2. [DOI] [PMC free article] [PubMed] [Google Scholar]